One-stop intravitreal injection model: expert consensus on establishment and management
10.3760/cma.j.cn511434-20230211-00041
- VernacularTitle:一站式玻璃体腔注药模式的建立与管理专家共识
- Author:
Xiaorong LI
1
;
Xiaoxin LI
;
Xun XU
Author Information
1. 天津医科大学眼科医院 天津医科大学眼科研究所 天津医科大学眼视光学院, 天津 300384
- Keywords:
Intravitreal injection;
Standard operating procedure;
Organization management;
Physician's practice patterns;
Quality control standard;
Expert consensus
- From:
Chinese Journal of Ocular Fundus Diseases
2023;39(3):187-193
- CountryChina
- Language:Chinese
-
Abstract:
Intravitreal drug injection is a treatment for common chronic fundus diseases such as age-related macular degeneration and diabetic retinopathy. The "14th Five-Year" National Eye Health Plan (2021-2025) recommends focusing on fundus diseases and improve the management mode of patients with chronic eye diseases. Therefore, it is imperative to explore how to further optimize the service process of intravitreal injection under the premise of guaranteeing patients' medical safety, to promote medical service efficiency and standardized management level and improve the medical experience of patients. Based on the quality control standard of vitreous cavity injection for retinopathy in China, Chinese fundus disease and related field experts developed the present expert consensus on the establishment of a one-stop intravitreal injection model and the management of its organization after a serious, comprehensive, and complete discussion, focusing on a standardized operation process, quality control, and safety management, providing more references for establishing a suitable intravitreal injection management model for ophthalmology and promoting the development of diagnostic and treatment models for fundus disease in China.
